NICE recommends ixekizumab for persistent severe plaque psoriasis

被引：0
|
作者：
Mayor, Susan
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2017年 / 356卷
关键词：
D O I：
10.1136/bmj.j1275
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] NICE recommends Humira for chronic plaque psoriasis
    不详
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (08) : 439 - 439
  • [2] Ixekizumab: A Review in Moderate to Severe Plaque Psoriasis
    Syed, Yahiya Y.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2017, 18 (01) : 147 - 158
  • [3] Ixekizumab: A Review in Moderate to Severe Plaque Psoriasis
    Yahiya Y. Syed
    [J]. American Journal of Clinical Dermatology, 2017, 18 : 147 - 158
  • [4] Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasis
    Cather, Jennifer Clay
    Young, Chaney T.
    Young, Melody S.
    Cather, J. Christian
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (08) : 983 - 990
  • [5] Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Bram L. T. Ramaekers
    Robert F. Wolff
    Xavier Pouwels
    Marije Oosterhoff
    Anoukh Van Giessen
    Gill Worthy
    Caro Noake
    Nigel Armstrong
    Jos Kleijnen
    Manuela A. Joore
    [J]. PharmacoEconomics, 2018, 36 : 917 - 927
  • [6] Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Ramaekers, Bram L. T.
    Wolff, Robert F.
    Pouwels, Xavier
    Oosterhoff, Marije
    Van Giessen, Anoukh
    Worthy, Gill
    Noake, Caro
    Armstrong, Nigel
    Kleijnen, Jos
    Joore, Manuela A.
    [J]. PHARMACOECONOMICS, 2018, 36 (08) : 917 - 927
  • [7] Ixekizumab: A Review of Its Use for the Management of Moderate to Severe Plaque Psoriasis
    Shelton, Sydney K.
    Bai, Sandra R.
    Jordan, Joseph K.
    Sheehan, Amy Heck
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (03) : 276 - 284
  • [8] Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium
    Carmona-Rocha, Elena
    Puig, Lluis
    [J]. IMMUNOTHERAPY, 2023, 15 (15) : 1209 - 1225
  • [9] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
    Gordon, K. B.
    Blauvelt, A.
    Papp, K. A.
    Langley, R. G.
    Luger, T.
    Ohtsuki, M.
    Reich, K.
    Amato, D.
    Ball, S. G.
    Braun, D. K.
    Cameron, G. S.
    Erickson, J.
    Konrad, R. J.
    Muram, T. M.
    Nickoloff, B. J.
    Osuntokun, O. O.
    Secrest, R. J.
    Zhao, F.
    Mallbris, L.
    Leonardi, C. L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04): : 345 - 356
  • [10] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
    Egeberg, Alexander
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2101 - 2102
12345